SpringWorks Therapeutics, Inc. short interest in 2024
In 2024, SpringWorks Therapeutics, Inc.'s disclosed short interest ran from 16.64% of shares outstanding on 12 Jan 2024 to 16.49% on 31 Dec 2024, a change of -0.15 percentage points. The year's high was 18.45% on 13 Sep 2024 and its low 13.52% on 30 Apr 2024, averaging 16.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.80 days on 13 Sep 2024. Full history: SpringWorks Therapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2024 in figures
- Start of year
- 16.64% (12 Jan 2024)
- End of year
- 16.49% (31 Dec 2024)
- Change
- -0.15 pp
- High
- 18.45% (13 Sep 2024)
- Low
- 13.52% (30 Apr 2024)
- Average
- 16.24%
- Highest days to cover
- 19.80 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 16.64% | 9.15 | |
| 31 Jan 2024 | 16.63% | 14.76 | |
| 15 Feb 2024 | 18.24% | 7.44 | |
| 29 Feb 2024 | 17.78% | 6.00 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 17.86% | 10.14 | |
| 28 Mar 2024 | 17.03% | 12.76 | |
| 15 Apr 2024 | 16.85% | 15.03 | |
| 30 Apr 2024 | 13.52% | 11.59 | |
| 15 May 2024 | 14.44% | 10.63 | 10-Q filed, results (8-K) |
| 31 May 2024 | 14.58% | 15.82 | |
| 14 Jun 2024 | 15.17% | 16.67 | |
| 28 Jun 2024 | 14.06% | 10.92 | |
| 15 Jul 2024 | 14.26% | 17.87 | |
| 31 Jul 2024 | 15.37% | 12.90 | |
| 15 Aug 2024 | 17.90% | 11.94 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 17.12% | 16.26 | |
| 13 Sep 2024 | 18.45% | 19.80 | |
| 30 Sep 2024 | 16.40% | 11.34 | |
| 15 Oct 2024 | 17.20% | 12.72 | |
| 31 Oct 2024 | 15.65% | 15.18 | |
| 15 Nov 2024 | 16.52% | 7.08 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 15.95% | 10.56 | |
| 13 Dec 2024 | 15.72% | 13.15 | |
| 31 Dec 2024 | 16.49% | 12.20 |
See also: SpringWorks Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.